Feucht & Leibold Lab
banner
teamjjtueb.bsky.social
Feucht & Leibold Lab
@teamjjtueb.bsky.social
🔬🧪CAR therapy, cancer genetics, senescence, cellular immunotherapy @UKTuebingen@CoE_iFIT @www.feucht-leibold-labs.com🧬🩸
Two members of TeamJJ, Viktoria and Julia, were awarded poster prices for their work. 🏅🥼
Congratulation to your TeamJJ members - well done! #TeamJJ
November 19, 2025 at 8:02 AM
Last week, Judith and Josef attended the second VHIO-BBVA Foundation Symposium on Cell-Based Therapies in Oncology in wonderful Barcelona ☀️
Judith gave a talk and presented work from TeamJJ on how to modulate signaling activities to enhance CAR-T cell potency. 🤩 #TeamJJ
November 17, 2025 at 11:22 AM
🌟 We’re excited to share some great news! 🌟
Our TeamJJ colleague Carolin has been accepted into the @dfg.de - funded MINT Clinician Scientist Program of the Medical Faculty Tübingen and is also receiving additional research funding from the „Förderverein für krebskranke Kinder Tübingen e.V.“. 💪👩‍⚕️
November 10, 2025 at 11:45 AM
On Saturday evening, we swapped our lab coats for stylish outfits and met up at the Kelter in Tübingen🌃✨ We toasted the wonderful events of the past few months and enjoyed a lovely evening together with good food🍸🧑‍🍳🍾
More great news will follow soon – stay tuned. #TeamJJ
October 26, 2025 at 7:57 PM
Reposted by Feucht & Leibold Lab
This year's “Life Sciences Bridge Award ” goes to Dr. Judith Feucht, Dr. Frauke Mücksch and Dr. Varun Venkataramani. Congratulations! Read more: www.aventis-foundation.org and bridge.aventis-foundation.org
September 27, 2025 at 10:31 AM
We are thrilled to share that Judith received the Life Sciences Bridge Award 2025 for her work in the CAR T-cell field! 🎉😊
Many thanks to the aventis foundation for this honor. ☀️
For more information visit: bridge.aventis-foundation.org/award-winner...
#TeamJJ
Judith Feucht: Coach of therapeutic immune cells › Life Sciences Bridge Award
Pediatric Hematology and Oncology, University Children's Hospital Tübingen
bridge.aventis-foundation.org
September 26, 2025 at 11:43 AM
Last month, Karlotta and Matea visited their first Natural Killer (NK) cell conference, NK2025, held in beautiful Hobart (Tasmania, Australia)! 🌞🌊 It was a great opportunity to present their research, connect with leading experts, and learn about the latest advances in NK cell science. 🥼🤗
July 7, 2025 at 3:21 PM
TeamJJ scores at the Children’s Hospital soccer tournament! The TeamJJ All-Star soccer enthusiasts once again secured the overall victory. They demonstrated great teamwork and endurance throughout the matches, with indispensable support from the sidelines. 😎​💯⚽​ #TeamJJ
July 4, 2025 at 11:54 AM
Steffen and Celina joined the Cancer Immunotherapy (CIMT) Annual Meeting in Mainz. 🔬☀️
It was a great experience filled with inspiring talks and engaging discussions in poster sessions.
Huge thanks to the iFIT – Cluster of Excellence PhD program for making the participation possible! 🎉
#TeamJJ
June 24, 2025 at 7:44 AM
Our journey as part of the IFIT Cluster of Excellence goes on! 🚀🌟
The german research foundation @dfg.de will support our cluster @unituebingen.bsky.social for the next years and we can continue our work in an outstanding research environment!
Thank you to everyone for their hard work and @dfg.de 👏
May 28, 2025 at 9:27 AM
We recently celebrated the completion of two Master's theses in TeamJJ! ✨☀️
Carlotta (📷 together with Philip and Mara) is now continuing her PhD in our group and Viktoria (📷 together with Hannah and Judith) is now joining us again for her MD thesis.
Congratulations and welcome back! 💪👋
#TeamJJ
May 20, 2025 at 8:16 AM
Greetings from Crete! 🇬🇷 Nadine represented our lab @aegeanconf.bsky.social on Immunometabolism and very much enjoyed the conference with interesting talks 💬, nice people ☺️, a lot of good food 🥗🍤 and sunshine ☀️. #TeamJJ
May 11, 2025 at 8:11 PM
Josef is back from #AACR2025 in Chicago where he presented his poster on "CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency" 📰🔬
Between the numerous sessions, Josef found time to record a short tour of the conference for all those who stayed at home! Link to video: bit.ly/3RL7ozJ 📽️✨
😢 Our iFIT journey at the Annual Meeting of the American Association for… | iFIT - Cluster of Excellence
😢 Our iFIT journey at the Annual Meeting of the American Association for Cancer Research is slowly coming to an end! 💪 Therefore, our member and research group leader 👨‍🔬 Josef Leibold took the time ...
bit.ly
May 4, 2025 at 6:39 PM
We are #hiring!! 🤩
Are you a passionate researcher looking for a PhD or postdoc position in the field of CAR T cell therapies, gene editing and cancer-immune cell interactions? Then apply to join our amazing team in beautiful Tübingen! 📩☀️
www.feucht-leibold-labs.com/vacancies
Vacancies | Feucht Leibold Lab Tübingen
We are hiring!
www.feucht-leibold-labs.com
April 7, 2025 at 2:30 PM
Our PhD students are back from their two-day trip to the first iFIT PhD Retreat with engaging workshops, social events and a lot of sun 😎🌞
See the LinkedIn post for more pictures and impressions: bit.ly/3XQmjfr
Thanks to the iFIT cluster, Sisi and Steffen for the organisation 💐😃
April 7, 2025 at 12:49 PM
TeamJJ comments on Merad & Brown Lab´s recently published paper in Cell about the role of cancer derived IL-4 in ovarian cancer (www.sciencedirect.com/science/arti...).
Check out the "Research Highlight" article in Signal Transduction and Targeted Therapy: www.nature.com/articles/s41...
#TeamJJ
February 18, 2025 at 8:53 AM
Judith presented our recent #CARTcell research at the 7th European CAR T cell Meeting #CART25 in Strasbourg.🧬🧫
Many thanks to the organizers @EHA_Hematology and @EBMT for this inspiring event.
#TeamJJ
February 12, 2025 at 10:15 AM
As 2024 is almost over, we want to summarize the past year here on Bluesky.
- We had several students defending their thesis and new members joining 🎓
- Grants! We were awarded the ERC starting grant, a grant from Deutsche Krebshilfe and the Württembergische Krebspreis 💥
- We went to conferences 📽
December 17, 2024 at 10:08 AM
Hello Bluesky! 🦋
TeamJJ is now here! We are happy to start our new account to share and discuss our research. 🔬🤩 #TeamJJ
December 17, 2024 at 9:44 AM